Litcius/Paper detail

HIV-1 reservoir size after neonatal antiretroviral therapy and the potential to evaluate antiretroviral-therapy-free remission (IMPAACT P1115): a phase 1/2 proof-of-concept study

Deborah Persaud, Yvonne J. Bryson, Bryan S Nelson, Camlin Tierney, Mark F. Cotton, Anne Coletti, Jennifer Jao, Stephen A. Spector, Mark Mirochnick, Edmund V. Capparelli, Diane Costello, Joseph Szewczyk, Nicol Nicodimus, Lynda Stranix‐Chibanda, Adeodata Kekitiinwa, Violet Korutaro, Christina Reding, Mary Carrington, Sai Majji, Dwight E. Yin, Patrick Jean‐Philippe, Ellen G. Chadwick

2023The Lancet HIV23 citationsDOIOpen Access PDF

Topics & Concepts

NevirapineMedicineCohortLopinavir/ritonavirLopinavirPediatricsViral loadGestational ageRitonavirCohort studyAntiretroviral therapyInternal medicineObstetricsPregnancyHuman immunodeficiency virus (HIV)ImmunologyBiologyGeneticsHIV Research and TreatmentHIV/AIDS Research and InterventionsCytomegalovirus and herpesvirus research
HIV-1 reservoir size after neonatal antiretroviral therapy and the potential to evaluate antiretroviral-therapy-free remission (IMPAACT P1115): a phase 1/2 proof-of-concept study | Litcius